Skip to main content
. 2024 Jun 26;14:14806. doi: 10.1038/s41598-024-64490-x

Table 3.

Change in the levels of significantly altered metabolites (n = 25) in MS group (n = 90) compared to control group (n = 30).

Metabolites p-valuea Fold change (MS vs Ctrl)b
Lysine 3.11E-19 **** ↓ (0.48)
myo-Inositol 6.13E-18 **** ↓ (0.36)
Glutamate 1.56E-16 **** ↓ (0.57)
Threonine 7.64E-16 **** ↓ (0.38)
Glycine 9.51E-15 **** ↓ (0.45)
Tyrosine 3.33E-12 **** ↓ (0.61)
Choline 5.18E-12 **** ↓ (0.50)
O-phosphocholine 1.79E-09 **** ↓ (0.54)
Serine 7.47E-08 **** ↓ (0.71)
Tryptophan 4.39E-07 **** ↑ (3.34)
Phenylalanine 9.54E-07 **** ↓ (0.64)
Cysteine 1.10E-06 **** ↓ (0.65)
Succinate 2.50E-06 **** ↑ (1.58)
Creatine 1.64E-05 **** ↓ (0.46)
ATP 1.11E-04 *** ↑ (1.98)
Creatine phosphate 1.39E-04 *** ↓ (0.49)
NAD +  1.77E-04 *** ↑ (1.90)
O-phosphoethanolamine 4.79E-04 *** ↓ (0.70)
Formate 5.65E-04 *** ↑ (2.47)
Inosine 1.24E-03 ** ↑ (1.61)
sn-glycero-3-phosphocholine 1.67E-03 ** ↓ (0.77)
Histidine 2.90E-03 ** ↑ (1.90)
Glutathione 3.29E-03 ** ↑ (1.47)
Pantothenate 5.54E-03 ** ↑ (1.37)
Fumarate 1.76E-02 * ↓ (0.57)

ap-values obtained by t-test, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

bMetabolites with ↑ indicates increased levels in serum of MS group while ↓ indicates decreased levels in serum of MS group compared to control group.